Back to Journals » OncoTargets and Therapy » Volume 16

Circular RNA Circ-Foxo3 Induced Cell Apoptosis in Urothelial Carcinoma via Interaction with miR-191-5p [Retraction]

Authors Wang C, Tao W, Ni S, Chen Q

Received 10 August 2023

Accepted for publication 10 August 2023

Published 11 August 2023 Volume 2023:16 Pages 693—694

DOI https://doi.org/10.2147/OTT.S434826



Wang C, Tao W, Ni S, Chen Q. Onco Targets Ther. 2019;12:8085–8094.

At the authors request, we, the Editor and Publisher of OncoTargets and Therapy have retracted the published article. Since publication, concerns have been raised to the authors about the integrity of the data in the article, including the duplication of images in Figure 6. Specifically,

  • The flow cytometry images for Figure 6C, T24, circFoxo3(-) miR191(-), circFoxo3(-) miR191(+), circFoxo3(+) miR191(-) and circFoxo3(+) miR191(+) have been duplicated with images for Figure 6C, T82, circFoxo3(-) miR191(-), circFoxo3(-) miR191(+), circFoxo3(+) miR191(-) and circFoxo3(+) miR191(+), respectively.

The authors explained they were unable to provide the original data for their study and the results could not be verified. As verifying the validity of the published work is core to the integrity of the scholarly record, the authors requested to retract the article and the editor and Publisher agreed with this decision.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.


This retraction relates to this paper


Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.